FULC
Fulcrum Therapeutics, Inc.
-0.00 (-0.13%)3.79USD272K成交股數289M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | 0.00-100% | 0.00 | – | 0.00-100% | 80.0M+8991% | 0.00 | 871K | 759K | 880K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 12.4M | 14.1M | 15.4M | 14.3M | 13.0M | 13.4M | 14.6M | 17.3M | 19.8M | 19.0M | 18.2M | 17.8M |
| 銷售管理費用 | 7.5M | 8.1M | 7.3M | 7.6M | 6.8M | 7.0M | 8.4M | 10.2M | 10.1M | 9.9M | 10.0M | 10.3M |
| 營業利益 | −29.3M+48% | −22.2M+9% | −22.7M-10% | −21.9M-142% | −19.8M-34% | −20.4M-27% | −25.1M-8% | 52.5M-292% | −29.8M | −28.0M | −27.4M | −27.3M |
| 營業利益率 | – | – | – | – | – | – | – | 65.6% | – | -3,213.8% | -3,615.3% | -3,101.4% |
| 稅後淨利 | −26.2M+51% | −18.9M+7% | −20.3M-6% | −19.6M-135% | −17.3M-36% | −17.7M-29% | −21.7M-10% | 55.4M-333% | −26.9M | −24.8M | −24.0M | −23.8M |
| 淨利率 | – | – | – | – | – | – | – | 69.3% | – | -2,842.8% | -3,164.3% | -2,702.6% |
| 稀釋 EPS | -0.34+21% | -0.25-11% | -0.31-11% | -0.31-136% | -0.28-35% | -0.28-32% | -0.35-10% | 0.87-329% | -0.43 | -0.41 | -0.39 | -0.38 |
| 稀釋股數 | 76.3M | 76.2M | 63.4M | 62.6M | 62.5M | 62.5M | 62.4M | 63.6M | 62.0M | 61.3K | 61.8M | 61.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 48.5M | 50.3M | 198M | 47.1M | 42.6M | 42.2M | 72.6M | 86.7M | 39.9M | 25.6M | 30.1M | 34.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 324M | 347M | 366M | 215M | 229M | 243M | 279M | 294M | 233M | 258M | 279M | 300M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 13.3M | 13.5M | 17.3M | 16.5M | 14.5M | 14.2M | 21.7M | 20.5M | 19.0M | 22.5M | 23.4M | 24.9M |
| 股東權益 | 311M | 333M | 349M | 198M | 214M | 228M | 257M | 274M | 214M | 235M | 255M | 275M |
| 負債比 | 4.1% | 3.9% | 4.7% | 7.7% | 6.3% | 5.8% | 7.8% | 7.0% | 8.2% | 8.7% | 8.4% | 8.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −18.8M+23% | – | – | – | −15.3M | – | – | −25.3M | – | – | – |
| 資本支出 | – | 8K | – | – | – | 0.00 | – | – | 28K | – | – | – |
| 自由現金流 | – | −18.8M+23% | – | – | – | −15.3M | – | – | −25.3M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −74.9M | –% | -1.18 | −60.4M |
| FY2024 | 80.0M | +2752.0% | −9.7M | -12.2% | -0.16 | −2.5M |
| FY2023 | 2.8M | -55.8% | −97.3M | -3,470.2% | -1.59 | −91.5M |
| FY2022 | 6.3M | -66.9% | −110M | -1,732.4% | -2.44 | −99.0M |
| FY2021 | 19.2M | +117.2% | −80.8M | -421.9% | -2.29 | −80.2M |
| FY2020 | 8.8M | – | −70.8M | -802.7% | -2.79 | −55.0M |
| FY2019 | – | – | −82.7M | –% | -8.13 | −40.3M |
| FY2018 | – | – | −32.6M | –% | -31.14 | −31.5M |